featured

Highlighting innovation

FROM THE BLOG

Our insights

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Senior Care
Sector Insight

Antibiotic Resistance - Has the COVID-19 pandemic fast-tracked us towards a pre-antibiotic era?

Throughout this series, we’ll be focusing onto antibiotics and the problem associated with antimicrobial resistance. Antimicrobial resistance (AMR) can occur when microorganisms gain mechanistic advantages which allow them to survive exposure to therapeutic agents such as antibiotics, antifungals, or antivirals. There are many ways microbes can obtain resistance, such as genetic mutations and the transfer of genes, but what proliferates and pushes resistance to happen more rapidly are selective pressures.

Author

January 12, 2023

Senior Care
Startup Spotlight

Umkele: The sustainability start-up spinning silk and making plastic with synthetic biology.

‘Umkele’ take their name from the Zulu word for the Puzzle Bush, a plant said to have magical properties. Like their namesake, Umkele are setting out to do something miraculous…

Author

December 16, 2022

Senior Care

Alt Atlas: Artificial Intelligence powering real meat of the future

Alt Atlas is taking a systemic approach to cultivated meat, by gaining an in-depth understanding of stem cells on a genomic, transcriptomic and metabolomic level. Through this, they are continuously developing optimised solutions that can plug in and out of industrial bio-processes. As the cell lines are linked to its proprietary platform, Alt Atlas allows a faster turnaround for an efficient manufacturing.

Author

Charles Leach

December 8, 2022

Senior Care
Sector Insight

Can the Rise of Methane-Reducing Feed Products Save the Planet?

The UK Government has recently launched a “call for evidence” to gather information about how animal feed products could be used to reduce methane emissions. Through this initiative, stakeholders can help contribute to future policy that shapes the type of animal feed we produce, aiming to reduce the environmental impact of livestock production.

Author

November 3, 2022

Senior Care
Startup Spotlight

Beta Buzz - A publication for the Insect Farming Industry

In a recent publication, Beta Bugs argued that farming requires redefinition. Pressure on farmers to consider alternative farm practices has been raised to a fever pitch, thanks to the 3-in-1 deleterious effects of food waste, deforestation, and carbon emissions of current farming methods. In navigating a viable way forward for the agricultural industry, farmers are increasingly shifting their attention to insect farming, which will help bring a new face to agriculture.

Author

November 2, 2022

Senior Care
Sector Insight

The Future of Food in the Metaverse

With Facebook's recent company name-switch to Meta, the Metaverse is a rapidly evolving concept that has hit many headlines in the past year. But how will the food industry be involved and what will food in the Metaverse look like?

Author

October 4, 2022

Senior Care
Innovators Club

SEC’s Innovators Club launches third cohort with six SynBio startups

London, September 2022 - The Innovators Club, a network accelerator programme run by non-profit Science Entrepreneur Club (SEC), has today announced its third cohort welcoming six startups innovating in the field of synthetic biology (SynBio).

Author

September 27, 2022

Senior Care
Sector Insight

Behind Spinraza's 95% price drop in China: Desperate or Pre-empted? (Part 2)

In Part 1 of the story we discussed the birth of Spinraza and its market access inChina. Here in Part 2, we will continue the story on the competitive landscape ofSMA drugs and Biogen’s revenue challenges in 2021.

Author

August 25, 2022

Senior Care
Sector Insight

Behind Spinraza's 95% price drop in China: Desperate or Pre-empted? (Part 1)

On November 3rd 2021, the Chinese National Healthcare and Security Administration (NHSA) announced updates on the National Reimbursement Drug List (NRDL). Out of the 85 new drugs being negotiated, 67 made it to the NRDL, with an average price drop of 61.7%. Of note was one drug, Spinraza (molecule name Nusinersen), which saw a 95% price slash from CNY 700,000 (US$108,500) to CNY 33,000 (US$5,180) per dose. Treating spinal muscular atrophy (SMA), Spinraza will be the first reimbursed medicine for this rare disease that affects only one in every 8 thousand new-borns in China.

Author

July 25, 2022

Senior Care

What is Personalised Nutrition?

The word 'personalised' in the world of nutrition may have started out as a trendy idea, but it has now started to become a serious reality. Companies have been jumping on board to offer personalised dietary advice, recommendations and even products based on individual characteristics.

Author

July 6, 2022

Sorry we couldn't find anything that matched.
Try adjusting your search terms.

Our latest updates. In your inbox. Once a month.

Sign up for our monthly newsletter of upcoming events, recently published insights and SEC updates.